Kinfo
Cryo-Cell International Inc. logo

Cryo-Cell International Inc.

CCELNYSEHealthcare·US · USD
$3.88
+0.37 (+10.54%)
Prices as of August 12, 2026 · live

Price

Key statistics

Valuation
Market cap31.28M USD
Enterprise value34.10M USD
Trailing P/E475.00
Forward P/E175.50
PEG ratio3.56
Price / sales0.91
Price / book-1.74
Profitability
Gross margin78.44%
Operating margin15.40%
Profit margin-7.92%
Return on assets-0.10%
Return on equity13.06%
Income (TTM)
Revenue31.13M USD
Gross profit19.90M USD
EBITDA5.25M USD
Net income-2.47M USD
Diluted EPS-$0.31
Rev. growth (YoY)-1.90%
Balance sheet
Total cash3.16M USD
Total debt8.96M USD
Debt / equity-0.50
Current ratio0.71
Book value / share-$2.20
Cash flow (TTM)
Operating cash flow6.32M USD
Levered free cash flow1.52M USD
Shares & price
Shares outstanding8.06M
Float4.06M
Held by institutions13.35%
Beta0.52
50-day MA$3.51
200-day MA$3.60
52-week high$5.01
52-week low$2.72
Dividends
Forward rate
$0.60
Yield
15.67%
Payout ratio
0.00%
Frequency
Annual
Recent payments
  • 2025-05-21$0.15
Earnings (EPS)
DateEst.ActualSurprise2026-07-150.072026-04-14-0.020.02+200.00%2026-02-27-0.09-0.47−422.22%2026-01-231.611.87+16.15%
About Cryo-Cell International Inc.

Cryo-Cell International Inc. is a prominent biotechnology company that specializes in cord blood and tissue banking services. Established with a focus on providing families with the opportunity to preserve vital biological resources, Cryo-Cell collects and stores umbilical cord blood and tissue at the time of a child's birth. These stored cells can potentially be used in future medical treatments due to their ability to differentiate into various cell types. The primary purpose of Cryo-Cell is to offer reliable and accessible solutions for parents wishing to safeguard their children's health against potential future illnesses, such as blood disorders and certain genetic diseases. Operating within the healthcare and biotech sectors, Cryo-Cell International Inc. plays a crucial role in the rapidly evolving field of regenerative medicine, contributing to advancements in cellular therapies and research. With its headquarters in Oldsmar, Florida, the company is a significant participant in the biotechnology industry, known for its emphasis on innovation, quality control, and adherence to rigorous industry standards. As a trusted entity in its domain, Cryo-Cell remains committed to expanding its scientific capabilities and enhancing the scope of its services, thereby impacting the broader medical and scientific communities.

Sector
Healthcare
Industry
Medical Care Facilities
CEO
Mr. David I. Portnoy
Employees
72
Headquarters
Oldsmar, FL, United States

Frequently asked questions about Cryo-Cell International Inc.